Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: A cross-sectional study

BMJ Open

Volumn 2, Issue 6, 2012, Pages

  Munyazesa, Elisaphane ^a   Emile, Ivan ^a   Mutimura, Eugene ^b   Hoover, Donald R ^c   Shi, Qiuhu ^d   McGinn, Aileen P ^e   Musiime, Stephenson ^f   Muhairwe, Fred ^g   Rutagengwa, Alfred ^h   Dusingize, Jean Claude ^b   Anastos, Kathryn ^e  

^a National Reference Laboratory   (Rwanda)

^b Women's Equity in Access to Care and Treatment ^*  (Rwanda)

^c RUTGERS UNIVERSITY   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f RWANDA BIOMEDICAL CENTER   (Rwanda)

^g Byumba District Hospital   (Rwanda)

^h Eastern Province Nyamata District Hospital   (Rwanda)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DAPSONE; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NEUTROPENIA; PREVALENCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 84873838331     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001600     Document Type: Article

References (32)

1. Rudnicka D, Schwartz O. Intrusive HIV-1-infected cells. Nat Immunol 2009;10:933-4.
2. Anastos K, Shi Q, French A, et al. Total lymphocyte count, hemoglobin and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1 infected women receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2004;35:383-92. (Pubitemid 38332799)
3. Steinman RM, Granelli-Piperno A, Pope M, et al. The interaction of immunodeficiency viruses with dendritic cells. Curr Top Microbiol Immunol 2003;276:1-30. (Pubitemid 36538345)
4. Lekkerkerker AN, van Kooyk Y, Geijtenbeek TB. Viral piracy: HIV-1 targets dendritic cells for transmission. Curr HIV Res 2006;4:169-76.
5. Obirikorang C, Yeboah FA. Blood hemoglobin measurements as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci 2009;16:102.
6. Ajayi AO, Ajayi EA, Fasakin KA. CD4+ T-lymphocytes cell counts in adults with human immunodeficiency virus infection at the medical department of a tertiary health institution in Nigeria. Ann Afr Med 2009;8:257-60.
7. Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81:449-70. (Pubitemid 27150288)
8. Aboulafia DM, Mitsuyasu RT. Hematologic abnormalities in AIDS Hematol Oncol Clin North Am 1991;5:195.
9. Mata-Marín JA, Gaytán-Martínez JE, Martínez-Martín RE, et al. Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study. BMC Res Notes 2010;3:230.
10. Levine A, Karim R, Mack W, et al. Neutropenia in human immunodeficiency virus infection: data from the Women's Interagency HIV Study. Arch Intern Med 2006;166:405-10.
11. Miguez-Burbano MJ, Jackson J Jr, Hadrigan S. Thrombocytopenia in HIV disease: clinical relevance, physiopathology and management. Curr Med Chem Cardiovasc Hematol Agents 2005;3:365-76. (Pubitemid 41264273)
12. Kirchhoff F, Silvestri G. Is Nef the elusive cause of HIV-associated hematopoietic dysfunction?. J Clin Invest 2008;118:1622-5. (Pubitemid 351632365)
13. Dilkshit B, Wanchu A, Sachdeva RK, et al. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disorders 2009;9:5.
14. Siegfried N, Uthaman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev 2010;(3): CD008272.
15. Wisaksana R, Sumantri R, Indrati AR, et al. Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia BMC Infect Dis 2011;11:213.
16. Anastos K, Ndamage F, Lu D, et al. Lipoprotein levels and cardiovascular risk in HIV infected and uninfected Rwandan women AIDS Res Ther 2010;7:34.
17. World Health Organisation. Nutritional anemia: report of a WHO Scientific Group. Geneva, Switzerland: World Health Organisation, 1968.
18. Levine AM, Berhane K, Masri-Lavine L, et al. Prevalence and correlates of anemia in a cohort of HIV-infected women: Women's Interagency HIV Study. JAIDS 2001;26:28-35. (Pubitemid 32115048)
19. Laboratory values of clinical importance. In: Petersdorf RG, Adams RDBraunwald E, et al., eds. Harrison's principles of internal medicine. 10th edn. New York: McGraw-Hill, 1983:A-3.
20. Mugisha JO, Shafer LA, Van der Paal L, et al. Anaemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Trop Med Int Health 2008;13:788-94. (Pubitemid 351678637)
21. Erhabor O, Ejele OA, Nwauche CA, et al. Some hematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective. Niger J Med 2005;14:33-8.
22. Mildvan D, Creagh T, Leitz G, et al. Anemia Prevalence Study Group. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 humans-immunodeficiencyvirus- infected patients: findings of the Anemia Prevalence Study Curr Med Res Opin 2007;23:43-55.
23. Masaisa F, Gahutu JB, Mukiibi J, et al. Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda Am J Trop Med Hyg 2011;84:456-60.
24. Ministry of Health (MOH) (Rwanda), National Institute of Statistics of Rwanda (NISR), and ICF Macro. Rwanda interim demographic and health survey 2007-08. Calverton, MD: MOH, NISR, and ICF Macro, 2009.
25. Storz JF, Moriyama H. Mechanisms of hemoglobin adaptation to high altitude hypoxia. High Alt Med Biol 2008;9:148-57. (Pubitemid 351913540)
26. Windsor J, Martin D. From mountain to bedside: understanding the clinical relevance of human acclimatization to high-altitude hypoxia Postgrad Med J 2008;84:622-7.
27. Saunders PU, Pyne DB, Gore CJ. Endurance training at altitude High Alt Med Biol 2008;10:135-48.
28. Firnhaber C, Smeaton L, Saukila N, et al. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis 2010;14: e1088-92.
29. Kimura S, Matsuda J, Ikematsu S, et al. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. AIDS 1990;4:1251-5.
30. Mauss S, Steinmetz HT, Willers R, et al. Induction of granulocyte colony-stimulating factor by acute febrile infection but not by neutropenia in HIV seropositive individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:430-4.
31. Toure S, Gabillard D, Inwoley A, et al. Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6 year cohort study in Abidjan, CÔte D'Ivoire. Trans R Soc Trop Med Hyg 2006;100:785-90. (Pubitemid 43863178)
32. Vannappagari V, Nkhoma ET, Atashili J, et al. Prevalence, severity and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy. Platelets 2011;22:611-18.